OVER 96% OF KIDS AGED 3-17 DEVELOPED ANTIBODIES AFTER JAB IN UAE

  • 10/08/2021

More than 96 per cent of children aged 3 to 17, who took part in the Sinopharm immune bridge study, developed antibodies to fight Covid-19.Over 900 children were part of the study that was conducted in Abu Dhabi.Authorities in the UAE had earlier this month approved the Sinopharm vaccine to be given to kids in this age group.Officials did not observe any serious side effects in the children who took part in the study. Of the vaccinated children, 29.7 per cent experienced pain in the injection site; 8 per cent had headaches and 3.7 per cent developed a fever.

Related News

COP28: UAE declares $30 billion climate fund
  • 01/12/2023
1st plane, carrying Palestinian children, arrives in UAE
  • 18/11/2023
UAE's Sultan Al-Neyadi returns to earth after six months
  • 05/09/2023
BRICS invites 6 countries, including Saudi Arabia and UAE, t ...
  • 25/08/2023
Saudi and UAE approves the release of 'Barbie'
  • 09/08/2023
UAE astronaut Sultan Al Neyadi posts pictures of Mecca taken ...
  • 30/06/2023
UAE says it withdraws from naval alliance
  • 01/06/2023
UAE implements new rules to manage disruptive passengers
  • 17/04/2023
16 killed in Dubai building blaze
  • 16/04/2023
Dubai's rising cost of living invites millionaires, driving ...
  • 05/04/2023
Sharjah's four day work week brings 90% increase in producti ...
  • 05/02/2023
CHANGE IN GRACE PERIOD, EXTENSION OF NON-RESIDENTS STAY WITH ...
  • 10/11/2022